Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Revenue

In the year 2025, Sunshine Lake Pharma had annual revenue of 4.82B CNY with 19.81% growth. Sunshine Lake Pharma had revenue of 2.88B in the half year ending December 31, 2025, a decrease of -6.75%.

• Revenue: 4.82B CNY
• Revenue Growth: +19.81%
• P/S Ratio: 3.92
• Revenue / Employee: 757.92K CNY
• Employees: 6,353
• Market Cap: 21.02B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.82B	796.16M	19.81%
Dec 31, 2024	4.02B	-2.28B	-36.15%
Dec 31, 2023	6.29B	2.55B	68.08%
Dec 31, 2022	3.74B	2.83B	309.83%
Dec 31, 2021	913.79M	-1.43B	-61.08%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 28, 2026

Data Sources Report a data error